Herbert B. Newton & Ekokobe Fonkem. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
9
24
.
Herbert B. Newton & Ekokobe Fonkem. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
45
58
.
Nicholas G. Avgeropoulos & Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
21
44
.
Yun-lan Li, Jiali Zhang, Dong Min, Zhou Hongyan, Niu Lin & Qing-shan Li. (2016) Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis. PLOS ONE 11:4, pages e0151502.
Crossref
Herbert B. Newton. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
41
53
.
Herbert B. Newton. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
9
22
.
Herbert B. Newton & Jose J. Otero. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors
11
28
.
Nicholas A. Butowski & Susan M. Chang. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
937
945
.
George A. AlexiouKalliopi Stefanaki, Maria Moschovi, Amalia Patereli, Neofytos Prodromou & Ourania Karentzou. (2010) Immunohistochemical Expression of Cell Cycle/Apoptosis Regulators and Epidermal Growth Factor Receptor in Pediatric Intracranial Ependymomas. Journal of Child Neurology 26:2, pages 195-198.
Crossref
Donald J. AbrahamRobertson Graeme. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
223
294
.
Patrick Y. Wen, Eudocia Quant, Jan Drappatz, Rameen Beroukhim & Andrew D. Norden. (2010) Medical therapies for meningiomas. Journal of Neuro-Oncology 99:3, pages 365-378.
Crossref
Andrew D. Norden & Patrick Y. Wen. 2010. Meningiomas. Meningiomas
667
679
.
Herbert B. Newton. 2010. Glioblastoma. Glioblastoma
1
42
.
Herbert B. Newton. (2009) Bevacizumab: Review of Development, Pharmacology, and Application to Brain Tumors. Clinical Medicine. Therapeutics 1, pages CMT.S2042.
Crossref
Warren P. MasonJ. Gregory Cairncross. (2008) Invited Article: The expanding impact of molecular biology on the diagnosis and treatment of gliomas. Neurology 71:5, pages 365-373.
Crossref
Herbert B. Newton. (2008) Glioblastoma multiforme. Current Treatment Options in Neurology 10:4, pages 285-294.
Crossref
Herbert B. Newton, Abhik Ray-Chaudhury & Mark G. Malkin. 2008. Handbook of Neuro-Oncology NeuroImaging. Handbook of Neuro-Oncology NeuroImaging
36
49
.
Herbert B. Newton, Abhik Ray-Chaudhury & Mark G. Malkin. 2008. Handbook of Neuro-Oncology NeuroImaging. Handbook of Neuro-Oncology NeuroImaging
9
19
.
Andrew D. Norden, Jan Drappatz & Patrick Y. Wen. (2007) Targeted drug therapy for meningiomas. Neurosurgical FOCUS 23:4, pages E12.
Crossref
Andrew D. Norden, Jan Drappatz & Patrick Y. Wen. (2007) Targeted drug therapy for meningiomas. Neurosurgical Focus 23:4, pages E12.
Crossref
Thais Federici & Nicholas M. Boulis. (2007) RIBONUCLEIC ACID INTERFERENCE FOR NEUROLOGICAL DISORDERS. Neurosurgery 60:1, pages 3-16.
Crossref
Nicholas A. Butowski, Patricia K. Sneed & Susan M. Chang. (2006) Diagnosis and Treatment of Recurrent High-Grade Astrocytoma. Journal of Clinical Oncology 24:8, pages 1273-1280.
Crossref
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
347
363
.